USPTO serial 79438311
NEMA HEALTH
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- GEISER, EMILY A
- Law office
- TMO LAW OFFICE 138
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with NEMA HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Anticancer drugs; anticancer preparations; pharmaceutical products; chemico-pharmaceutical products; regenerative tissue [pharmaceutical preparations]; bacteriological preparations for pharmaceutical use; synthetic peptides for pharmaceutical use; chemical preparations for pharmaceutical use; chemical products for pharmaceutical purposes; pharmaceutical preparations containing stem cells; pharmaceutical products for cancer treatment; transdermal patches for administering pharmaceutical products; filled syringes for medical purposes containing pharmaceuticals; medical products; cells for medical use; diagnostic preparations for medical use in medical laboratories; immunoassay reagents for medical use; reagents with biomarkers for medical diagnostics; diagnostic preparations for medical use; diagnostic substances for medical use; diagnostic preparations and materials for medical and veterinary use; hygienic preparations for medical use. | ACTIVE | — |
| 042 | Scientific research; biotechnological research; biochemical research; biological research, clinical research and medical research; genetic research; chemical research; research services; pharmaceutical research and development; scientific research and development; consultancy regarding pharmaceutical research; scientific analysis and research services; research in the field of nanobiotechnology; medical and pharmacological research services; research and development of pharmaceutical preparations for treating malignant tumors; consultancy relating to pharmaceutical research and development; research in the field of pharmacogenetics; information on scientific research in the field of biochemistry and biotechnology; research and development services in immunology; research in the field of immunodeficiency; scientific and technological design; scientific design services; scientific and technological services; scientific testing services; scientific research for medical purposes; consulting in the field of scientific research; technological and scientific services; scientific laboratory services; research in the field of genetic diseases; medical research in the field of rare diseases; research in the field of gene therapies; advisory services relating to gene therapy research. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 18, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 24, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 24, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 13, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 12, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 10, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 5, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 5, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 4, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |